Ravi Agrawal, a promoter of Ajanta Pharma Limited, has announced the release of pledge on 23,26,289 equity shares. This action, effective June 16, 2026, was undertaken due to an ‘Excess Pledge’ situation. The disclosure also details the specifics of the share release across various entities related to the promoter, with reasons cited as business financing.
Share Pledge Release Announced
Ravi Agrawal, a promoter of Ajanta Pharma Limited, has formally disclosed the release of pledge on a substantial holding of 23,26,289 equity shares of the company. The effective date for this release was June 16, 2026. The stated reason for this significant release of pledged shares is attributed to an ‘Excess Pledge’ scenario.
Details of Share Release
The disclosure, made in accordance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, outlines the release of pledge across several entities associated with the promoter. Key releases include:
- Ravi P. Agrawal, trustee Ravi Agrawal Trust: Release of 700,000 shares (0.56% of total share capital), with the beneficiary being Adity Birla Capital Limited.
- Ravi P. Agrawal: Release of 907,904 shares (0.73% of total share capital), benefiting Bajaj Finance Limited.
- Ravi P. Agrawal: Release of another 476,289 shares (0.38% of total share capital), held in favor of HSBC Direct Invest Financial Services Pvt Ltd.
- Ravi P. Agrawal: Release of 242,096 shares (0.19% of total share capital), also with Bajaj Finance Limited.
These releases were categorized under ‘Pledge Release’ and were for the purpose of ‘Business Financing’. The current holding of encumbered shares post-release has been updated accordingly for each entity.
Regulatory Compliance
The disclosure also includes information for other related entities such as ‘Gabs Investments Pvt Ltd’, ‘Yogesh M Agrawal, trustee Yogesh Agrawal Trust’, ‘Mannalal B Agrawal’, ‘Rajesh M Agrawal, trustee Rajesh Agrawal Trust’, ‘Aayush M Agrawal, trustee Aayush Agrawal Trust’, and ‘Aayush M. Agrawal’. The document was signed by Ravi Agrawal, acting as Trustee for the Ravi Agrawal Trust, and dated June 17, 2026.
Source: BSE
